Peptide Receptor Radionuclide Therapy in a Patient with SDHB Related Grade 3 Paraganglioma (PGL) of Urinary Bladder

#1833

Introduction: SDHB mutation cause aggressive metastatic PGL.36% of patients survive 5 yrs,treatment options are limited & many still being evaluated

Aim(s): 1st case of SDHB bladder PGL treated with Lu-177 DOTATATE

Materials and methods: Review presentation,biochemistry,histology,imaging,therapy effect & survival

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Steyn R, Prasad V,

Keywords: SDHB, Bladder PGL, PRRT ,

To read the full abstract, please log into your ENETS Member account.